Azithromycin
Athanor · official
C38H72N2O12 · 749 g/mol
IUPAC name: (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
Also called Zithromax, Z-Pak, azalide, macrolide antibiotic
Names and identifiers
- IUPAC name
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
- Synonyms
- Zithromax, Z-Pak, azalide
+ 38 more
macrolide antibiotic, Hemomycin, Azithromycine, Azasite, Azithromycinum, Zitromax, Azenil, aziromycin, Azithrocin, Azitrocin, Macrozit, Azitromicina, Aruzilina, azithromycin anhydrous, Trozocina, Xithrone, Zithromac, Zythromax, Aziwin, DuraSite, CP 62993, Anhydrous azithromycin, Azyter, DTXSID8030760, J2KLZ20U1M, XZ-450, NSC643732, XZ 405, XZ 450, NSC-758625, Azithromycin (as dihydrate), CP-62,993, CHEBI:2955, DTXCID6010760, Azadose, Ultreon, N-Methyl-11-aza-10-deoxo-10-dihydroerythromycin A, 1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-, (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-
- Molecular formula
- C38H72N2O12
- Empirical formula
- C19H36NO6
- Molecular weight
- 749 g/mol
- Exact mass
- 748.50853
- CAS number
- 83905-01-5
- PubChem CID
- 447043
- Canonical SMILES
- CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
- Isomeric SMILES
- CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
- InChI
- InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
- InChIKey
- MQTOSJVFKKJCRP-BICOPXKESA-N
- Molfile
Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.
Physical properties
Each value as its source reports it, with the source's number after it (listed under References). Where several sources report a property, the row shows the value most of them agree on, the rule the app uses; open the values to see every one.
Calculated
- Heavy atoms
- 52
- Rings
- 3
- Aromatic rings
- 0
- Fraction sp³ carbons (Fsp3)
- 0.97
- H-bond donors
- 5
- H-bond acceptors
- 14
- Rotatable bonds
- 7
- TPSA (Ų)
- 180.1 computed here · PubChem 180
- Formal charge
- 0
- XLogP3
- 4 PubChem
- Complexity
- 1150 PubChem
- Stereocenters
- 18 definedCIP: C3: R · C7: R · C9: S · C11: R · C13: R · C17: S · C19: S · C22: S · C24: R · C26: S · C28: R · C31: R
- Double-bond geometry
- None specified
- Point group
- C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)
Elemental analysis
- C60.94%
- H9.69%
- N3.74%
- O25.63%
Isotope pattern
Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.
Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.
Predicted
- log P
- 1.9 Crippen (Wildman and Crippen 1999)
- log S (water solubility)
- -5.22 ESOL (Delaney 2004), log mol/L
- Synthetic accessibility
- 6.13 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)
Drug-likeness: Lipinski’s rule of five
- Molecular weight ≤ 500: 749
- log P ≤ 5 (Crippen): 1.9
- H-bond donors ≤ 5: 5
- H-bond acceptors ≤ 10: 14
Breaks 2 of the four rules.
¹³C NMR shifts, predicted
Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.
Safety
Danger
Most widely reported: 122 company reports to ECHA. Source [2].
Harmful or irritant
Health hazard
Environmental hazard
- H317May cause an allergic skin reaction (97.5% of reports)
- H334May cause allergy or asthma symptoms or breathing difficulties if inhaled (96.7% of reports)
- H372Causes damage to organs through prolonged or repeated exposure (28.7% of reports)
- H400Very toxic to aquatic life (29.5% of reports)
- H410Very toxic to aquatic life with long lasting effects (30.3% of reports)
Precautionary statements: P233, P260, P261, P264, P270, P271, P272, P273, P280, P284, P302+P352, P304+P340, P319, P321, P333+P317, P342+P316, P362+P364, P391, P403, P501
Storage
- Store in tight container as defined in the usp-nf. This material should be handled and stored per label instructions to ensure product integrity.[1]
- Store in tight, light-resistant container as defined in the usp-nf. This material should be handled and stored per label instructions to ensure product integrity. Store in a freezer.[1]
- Commercially available azithromycin 250- or 500-mg tablets should be stored at 15-30 °C.[1]
- Azithromycin powder in single-dose packets for oral suspension should be stored at 5-30 °C. Following reconstitution, the entire contents of the single-dose packet should be ingested immediately.10 Azithromycin powder for extended-release oral suspension should be stored at 30 °C or lower. Following reconstitution, azithromycin single-dose extended-release oral suspension should be stored in the original bottle at 25 °C but may be exposed to 15-30 °C. The reconstituted suspension should be consumed within 12 hours.[1]
Safety data sheets on the supplier’s page: LGC Standards, CymitQuimica, MuseChem.
Always read the supplier’s safety data sheet before working with it.
Spectra
- 1H NMRHuman Metabolome Database (HMDB) (Bruker · 600 MHz · 100%_DMSO)
- 1H-13C NMRHuman Metabolome Database (HMDB) (Bruker · 600 MHz · 100%_DMSO)
- MS-MSHuman Metabolome Database (HMDB) (LC-ESI-qTof · Positive) · Human Metabolome Database (HMDB) (LC-ESI-qTof · Positive) · Human Metabolome Database (HMDB) (LC-ESI-qTof · Positive) · Human Metabolome Database (HMDB) (positive) · Human Metabolome Database (HMDB) (positive) · Human Metabolome Database (HMDB) (Positive)
- LC-MSMassBank Europe (Exploris 480 Orbitrap (Thermo Scientific) · LC-ESI-QFT · POSITIVE) · MassBank Europe (Exploris 480 Orbitrap (Thermo Scientific) · LC-ESI-QFT · NEGATIVE) · MassBank Europe (Bruker maXis Impact · LC-ESI-QTOF · POSITIVE) · MassBank of North America (MoNA) (qTof · positive) · MassBank of North America (MoNA) (qTof · positive) · MassBank of North America (MoNA) (qTof · positive)
- Other MSMassBank of North America (MoNA) (Orbitrap · positive) · MassBank of North America (MoNA) (Orbitrap · positive) · MassBank of North America (MoNA) (Orbitrap · negative)
- FTIRSpectraBase (Bio-Rad FTS · KBr0)
- ATR-IRSpectraBase (Bio-Rad FTS · ATR-Neat (DuraSamplIR II))
- RamanSpectraBase (FT-Raman)
Experimental spectra held by these sources; each link opens the source's own record.
Literature
Reading PubChem, OpenAlex and GSRS…
Bioactivity
Reading ChEMBL…
References
- [1]Hazardous Substances Data Bank (HSDB) · Public domain (US NLM) · via PubChem · retrieved 2026-10-14
- [2]European Chemicals Agency (ECHA) · ECHA legal notice: reuse with acknowledgement · via PubChem · retrieved 2026-10-14
- [3]Human Metabolome Database (HMDB) · Linked only · via PubChem · retrieved 2026-10-14
- [4]NIST Mass Spectrometry Data Center · Linked only · via PubChem · retrieved 2026-10-14
- [5]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
- [6]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
- [7]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
- ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
- ·Literature on PubChem
Data last updated 2026-10-14.
